Global Infantile Spasms Therapeutics Market by Dosage (Liquid, Solid), Route of Administration (Oral, Parental) - Forecast 2024-2030- Product Image

Sale

Global Infantile Spasms Therapeutics Market by Dosage (Liquid, Solid), Route of Administration (Oral, Parental) - Forecast 2024-2030

Report
180 Pages
March 2024
Region: Global
360iResearch™
ID: 4904865

UP TO €845EUR$875USD£723GBP OFF until Dec 31^st 2024

The Infantile Spasms Therapeutics Market size was estimated at USD 381.75 million in 2023, USD 406.01 million in 2024, and is expected to grow at a CAGR of 6.44% to reach USD 591.24 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infantile Spasms Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infantile Spasms Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Infantile Spasms Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Anavex Life Sciences Corp., Cerecin Inc., H. Lundbeck A/S, Lupin Limited, Mallinckrodt Pharmaceuticals, MSN Laboratories Private Limited, ORPHELIA Pharma, Ovid Therapeutics Inc., and Zydus Group.

Market Segmentation & Coverage

This research report categorizes the Infantile Spasms Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Dosage
- Liquid
- Solid
Route of Administration
- Oral
- Parental

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Infantile Spasms Therapeutics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infantile Spasms Therapeutics Market?
What are the technology trends and regulatory frameworks in the Infantile Spasms Therapeutics Market?
What is the market share of the leading vendors in the Infantile Spasms Therapeutics Market?
Which modes and strategic moves are suitable for entering the Infantile Spasms Therapeutics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Infantile Spasms Therapeutics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of central nervous system (CNS) infection
5.1.1.2. Rising penetration rate of infantile spasm drugs
5.1.1.3. Awareness by government and private organizations to decrease the number of undiagnosed cases
5.1.2. Restraints
5.1.2.1. High cost of treatment and lack of proper diagnosis of infantile spasm
5.1.3. Opportunities
5.1.3.1. Expanding scientific advancements in the treatment for infantile spasms
5.1.3.2. Increasing extensive research and development activities
5.1.4. Challenges
5.1.4.1. Stringent regulations for drug approval
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Infantile Spasms Therapeutics Market, by Dosage

6.1. Introduction
6.2. Liquid
6.3. Solid

7. Infantile Spasms Therapeutics Market, by Route of Administration

7.1. Introduction
7.2. Oral
7.3. Parental

8. Americas Infantile Spasms Therapeutics Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Infantile Spasms Therapeutics Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Infantile Spasms Therapeutics Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. Anavex Life Sciences Corp.
12.1.2. Cerecin Inc.
12.1.3. H. Lundbeck A/S
12.1.4. Lupin Limited
12.1.5. Mallinckrodt Pharmaceuticals
12.1.6. MSN Laboratories Private Limited
12.1.7. ORPHELIA Pharma
12.1.8. Ovid Therapeutics Inc.
12.1.9. Zydus Group
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. INFANTILE SPASMS THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INFANTILE SPASMS THERAPEUTICS MARKET DYNAMICS
FIGURE 7. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
FIGURE 8. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. INFANTILE SPASMS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. INFANTILE SPASMS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. INFANTILE SPASMS THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 6. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 9. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY PARENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 14. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 16. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 18. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 19. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 20. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 21. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. AUSTRALIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. CHINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 31. CHINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. INDIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 33. INDIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. INDONESIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. JAPAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 37. JAPAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. MALAYSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. PHILIPPINES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. SINGAPORE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. SOUTH KOREA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. TAIWAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. THAILAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 49. THAILAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. VIETNAM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 56. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. EGYPT INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 58. EGYPT INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. FINLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 60. FINLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 62. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 64. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. ISRAEL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 68. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. NIGERIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. NORWAY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 74. NORWAY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. POLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 76. POLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. QATAR INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 78. QATAR INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 86. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. SWEDEN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. SWITZERLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. TURKEY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 92. TURKEY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. INFANTILE SPASMS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 98. INFANTILE SPASMS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 99. INFANTILE SPASMS THERAPEUTICS MARKET LICENSE & PRICING

Companies Mentioned

Anavex Life Sciences Corp.
Cerecin Inc.
H. Lundbeck A/S
Lupin Limited
Mallinckrodt Pharmaceuticals
MSN Laboratories Private Limited
ORPHELIA Pharma
Ovid Therapeutics Inc.
Zydus Group

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	180
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 406.01 Million
Forecasted Market Value ( USD ) by 2030	$ 591.24 Million
Compound Annual Growth Rate	6.4%
Regions Covered	Global
No. of Companies Mentioned	9

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3259EUR$3,374USD£2,789GBP €3621EUR$3,749USD£3,099GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4128EUR$4,274USD£3,533GBP €4587EUR$4,749USD£3,925GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4997EUR$5,174USD£4,276GBP €5552EUR$5,749USD£4,752GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5866EUR$6,074USD£5,020GBP €6518EUR$6,749USD£5,578GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7605EUR$7,874USD£6,508GBP €8450EUR$8,749USD£7,231GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Infantile Spasms Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Infantile Spasms Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Global Infantile Spasms Therapeutics Market 2024-2028

Infantile Spasm - Pipeline Insight, 2024

West Syndrome - Pipeline Insight, 2024

About the Market